To assess whether the anti-IL-10 neutralizing antibody was inducing inflammation itself, mice were treated with anti-IL-10 antibody or control antibody via the intranasal route in the absence of concurrent bacterial infection. This evidence concerns the gene IL10 and bacterial infectious disease.